The latest industry information published by Credence Research “Global Breast Biopsy Devices industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the breast biopsy devices industry was valued at USD 617.62 Mn in 2015, and is expected to reach USD 1,250.71 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.
Breast cancer is among the most commonly diagnosed non-skin cancer across the world, with among the highest annual mortality. While the incidence of the disease is increasing at alarming rates in the developing industrys, the breast cancer survival prognosis is informationed to be con tenuously improving this proving development in the trends of early disease diagnosis and treatment outcomes. Pathological detection of breast cancer has evolved a long way until present with biopsy becoming the standard route of disease detection. With the introduction of minimally invasive biopsy procedures, intimating with fine needle aspiration, the global breast biopsy devices industry has witnessed phenomenal growth over the period. Rapidly aging population and the proven correlation of age with the incidence of breast cancer is among the biggest contributors to the breast biopsy devices industry. Alarming disease incidence and technological development resulting in rapid adoption of breast biopsy devices and related solutions are observed to be the major industry drivers in the developing regions of the world. Introduction of guidance enabled biopsy systems has further facilitated the industry development and assisted in containment of breast cancer incidence.
Browse the full report Breast Biopsy Devices Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/breast-biopsy-devices-market
industry Competition Assessment
Te global breast biopsy devices industry is consolidated with a few players dominating the major chunk of the industry revenue. Players such as Hologic, Mammotome, C.R. Bar, Inc. are identified and recognized as the global industry leaders. Other players such as Argon Medical Devices, Becton Dickinson and Company, Sterylab are the promising industry players with their established positions in prime industry segments.
Key industry Movements
Increased preference for minimally invasive biopsies
Rapid shift towards guided biopsies
Growth in adoption of disposable consumables
Request free Sample : http://www.credenceresearch.com/sample-request/57742
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US